Overview
Francesca Lunghi practices practicing medicine in Milan, Italy.
Ms. Lunghi is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Leukemia, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 4 clinical trials.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Frequently Asked Questions about Francesca Lunghi
Is Francesca Lunghi a top-rated expert for Chronic Myelogenous Leukemia (CML)?
MediFind is an objective health platform that identifies experts based on real-world data. Francesca Lunghi is classified as an Distinguished expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Francesca Lunghi participate in research or clinical trials?
Yes. Francesca Lunghi has published 49 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Francesca Lunghi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantMs. Lunghi isDistinguished. Learn about Bone Marrow Transplant.
- Chronic Myelogenous Leukemia (CML)Ms. Lunghi isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Myeloproliferative Neoplasms (MPN)Ms. Lunghi isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMs. Lunghi isDistinguished. Learn about Polycythemia Vera.
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- COVID-19Ms. Lunghi isAdvanced. Learn about COVID-19.
- Essential ThrombocythemiaMs. Lunghi isAdvanced. Learn about Essential Thrombocythemia.
- Graft Versus Host Disease (GvHD)Ms. Lunghi isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaMs. Lunghi isAdvanced. Learn about Leukemia.
- MyelofibrosisMs. Lunghi isAdvanced. Learn about Myelofibrosis.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Lunghi isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Blood ClotsMs. Lunghi isExperienced. Learn about Blood Clots.
- LeukocytosisMs. Lunghi isExperienced. Learn about Leukocytosis.
- Philadelphia-Negative Chronic Myeloid Leukemia
- PneumoniaMs. Lunghi isExperienced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)